Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oryan Henig

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
The Journal of Antimicrobial Chemotherapy|October 14, 2024
Impact of discontinuing routine fluoroquinolone prophylaxis in neutropenic allogeneic haematopoietic stem cell transplant recipients: an observational studyAnat Stern, Israel Henig, Maya Cohen, et al.
Infection and Drug Resistance|September 27, 2018
Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant <i>Enterobacteriaceae</i>Lindsay A Petty, Oryan Henig, Twisha S Patel, et al.
Microbiology Spectrum|February 5, 2025
Antibiotic susceptibility of pathogens isolated in respiratory tract samples of recently hospitalized patientsAnat Reiner-Benaim, Oryan Henig, Pilar Coronel, et al.
Shock (Augusta, Ga.)|January 16, 2016
OXYGEN MITIGATES THE INFLAMMATORY RESPONSE IN A MODEL OF HEMORRHAGE AND ZYMOSAN-INDUCED INFLAMMATIONMichal A Rahat, Vera Brod, Bat-Chen Amit-Cohen, et al.
JAMA|May 6, 2021
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care WorkersYoel Angel, Avishay Spitzer, Oryan Henig, et al.
The Journal of Antimicrobial Chemotherapy|July 26, 2015
Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort studyNizar Andria, Oryan Henig, Offer Kotler, et al.
Open Forum Infectious Diseases|February 21, 2022
The Performance of Sepsis-3 Criteria to Predict Mortality Among Patients With Hematologic Malignancy and Post-transplant who Have Suspected InfectionOryan Henig, Rosemary K B Putler, Owen Albin, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 11, 2022
Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibilityLiat Shargian, Mical Paul, Tal Nachshon, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
The Hypothetical Impact of Accelerate Pheno on Time to Effective Therapy and Time to Definitive Therapy for Bloodstream Infections Due to Drug-Resistant Gram-Negative BacilliOryan Henig, Keith S Kaye, Suganya Chandramohan, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Antibiotic Use during the COVID-19 Pandemic in a Tertiary Hospital with an Ongoing Antibiotic Stewardship ProgramOryan Henig, Orli Kehat, Suzy E Meijer, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Antimicrobial Chemotherapy|October 14, 2024
Impact of discontinuing routine fluoroquinolone prophylaxis in neutropenic allogeneic haematopoietic stem cell transplant recipients: an observational studyAnat Stern, Israel Henig, Maya Cohen, et al.
Infection and Drug Resistance|September 27, 2018
Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant <i>Enterobacteriaceae</i>Lindsay A Petty, Oryan Henig, Twisha S Patel, et al.
Microbiology Spectrum|February 5, 2025
Antibiotic susceptibility of pathogens isolated in respiratory tract samples of recently hospitalized patientsAnat Reiner-Benaim, Oryan Henig, Pilar Coronel, et al.
Shock (Augusta, Ga.)|January 16, 2016
OXYGEN MITIGATES THE INFLAMMATORY RESPONSE IN A MODEL OF HEMORRHAGE AND ZYMOSAN-INDUCED INFLAMMATIONMichal A Rahat, Vera Brod, Bat-Chen Amit-Cohen, et al.
JAMA|May 6, 2021
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care WorkersYoel Angel, Avishay Spitzer, Oryan Henig, et al.
The Journal of Antimicrobial Chemotherapy|July 26, 2015
Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort studyNizar Andria, Oryan Henig, Offer Kotler, et al.
Open Forum Infectious Diseases|February 21, 2022
The Performance of Sepsis-3 Criteria to Predict Mortality Among Patients With Hematologic Malignancy and Post-transplant who Have Suspected InfectionOryan Henig, Rosemary K B Putler, Owen Albin, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 11, 2022
Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibilityLiat Shargian, Mical Paul, Tal Nachshon, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
The Hypothetical Impact of Accelerate Pheno on Time to Effective Therapy and Time to Definitive Therapy for Bloodstream Infections Due to Drug-Resistant Gram-Negative BacilliOryan Henig, Keith S Kaye, Suganya Chandramohan, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Antibiotic Use during the COVID-19 Pandemic in a Tertiary Hospital with an Ongoing Antibiotic Stewardship ProgramOryan Henig, Orli Kehat, Suzy E Meijer, et al.
Pageof 4